Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for RCDTF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 6.138B
March 31, 2026 6.146B
December 31, 2025 6.169B
September 30, 2025 6.226B
June 30, 2025 6.076B
March 31, 2025 5.580B
December 31, 2024 5.317B
September 30, 2024 4.691B
June 30, 2024 4.502B
March 31, 2024 4.624B
December 31, 2023 4.649B
September 30, 2023 4.480B
June 30, 2023 4.591B
March 31, 2023 4.326B
December 31, 2022 4.268B
September 30, 2022 3.897B
June 30, 2022 4.165B
March 31, 2022 4.053B
December 31, 2021 3.203B
September 30, 2021 3.395B
June 30, 2021 3.411B
March 31, 2021 3.335B
December 31, 2020 3.318B
September 30, 2020 3.295B
June 30, 2020 3.156B
Date Value
March 31, 2020 3.097B
December 31, 2019 3.153B
September 30, 2019 2.924B
June 30, 2019 2.470B
March 31, 2019 2.495B
December 31, 2018 2.473B
September 30, 2018 2.393B
June 30, 2018 2.353B
March 31, 2018 2.426B
December 31, 2017 2.469B
September 30, 2017 2.382B
June 30, 2017 2.019B
March 31, 2017 1.789B
December 31, 2016 1.646B
September 30, 2016 1.818B
June 30, 2016 1.741B
March 31, 2016 1.752B
December 31, 2015 1.596B
September 30, 2015 1.672B
June 30, 2015 1.653B
March 31, 2015 1.584B
December 31, 2014 1.664B
September 30, 2014 1.853B
June 30, 2014 1.851B
March 31, 2014 1.859B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
AstraZeneca PLC 114.02B
ANI Pharmaceuticals, Inc. 1.494B
Corcept Therapeutics, Inc. 888.70M
Veru, Inc. 37.03M
Avadel Pharmaceuticals Plc 199.45M

Total Assets (Quarterly) Related Metrics